Add Yahoo as a preferred source to see more of our stories on Google. Some adults who take prescription medication for attention-deficit/hyperactivity disorder are ...

Immunocore (IMCR) announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous ...